What are the primary uses of cefazolin. How is cefazolin administered. What are the common side effects of cefazolin. How does cefazolin interact with other medications. What precautions should be taken when using cefazolin. What is the recommended dosage for cefazolin. How does cefazolin work in the body.

Understanding Cefazolin: An Overview of the Antibiotic

Cefazolin, commonly known by its brand name Ancef, is a first-generation cephalosporin antibiotic widely used in medical practice. This powerful medication plays a crucial role in treating various bacterial infections and preventing surgical site infections. To fully grasp the importance of cefazolin, it’s essential to delve into its mechanisms, applications, and considerations for use.

What is Cefazolin?

Cefazolin is a beta-lactam antibiotic that belongs to the cephalosporin family. It works by interfering with bacterial cell wall synthesis, ultimately leading to the death of susceptible bacteria. This antibiotic is particularly effective against gram-positive organisms and some gram-negative bacteria, making it a versatile choice for many infections.

Primary Uses and Indications for Cefazolin

Cefazolin is prescribed for a variety of bacterial infections and preventive measures. Its broad spectrum of activity makes it suitable for treating infections in different parts of the body.

Therapeutic Uses

• Respiratory tract infections
• Skin and soft tissue infections
• Bone and joint infections
• Urinary tract infections
• Septicemia (blood infections)
• Endocarditis

Prophylactic Uses

One of the most common applications of cefazolin is for surgical prophylaxis. It is administered before, during, or after certain surgical procedures to prevent postoperative infections.

Can cefazolin be used for all types of surgeries? While cefazolin is effective for many surgical procedures, it may not be suitable for all types. The choice of antibiotic for surgical prophylaxis depends on various factors, including the type of surgery, patient allergies, and local bacterial resistance patterns.

Administration and Dosage Forms of Cefazolin

Cefazolin is available in various formulations and can be administered through different routes, depending on the clinical situation and patient needs.

Routes of Administration

1. Intramuscular (IM) injection
2. Intravenous (IV) injection or infusion
3. Parenteral administration

Available Dosage Forms

Cefazolin comes in multiple strengths and formulations to accommodate different dosing requirements:

• Powder for solution: 250 mg, 500 mg, 1 g, 2 g, 10 g, 20 g vials
• Premixed solutions: 1 g/50 mL, 2 g/50 mL, 2 g/100 mL
• Injection solutions: Various concentrations from 100 mg/mL to 330 mg/mL

How is the appropriate dosage of cefazolin determined? The dosage of cefazolin is based on several factors, including the type and severity of infection, patient age, weight, kidney function, and the specific formulation being used. Healthcare providers carefully calculate the appropriate dose to ensure optimal therapeutic effect while minimizing the risk of side effects.

Mechanism of Action: How Cefazolin Fights Bacteria

Understanding how cefazolin works in the body is crucial for appreciating its effectiveness and potential limitations.

Cell Wall Inhibition

Cefazolin targets the bacterial cell wall, specifically interfering with the final stage of peptidoglycan synthesis. This process weakens the cell wall, leading to bacterial cell lysis and death.

Spectrum of Activity

Cefazolin is particularly effective against:

• Gram-positive bacteria: Staphylococcus aureus (including methicillin-susceptible strains), Streptococcus pneumoniae, and group A beta-hemolytic streptococci
• Some gram-negative bacteria: Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae

Does cefazolin work against all types of bacteria? No, cefazolin is not effective against all bacterial species. It has limited activity against anaerobic bacteria, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus (MRSA). The choice of antibiotic should always be based on the suspected or confirmed pathogens and their susceptibility patterns.

Side Effects and Adverse Reactions Associated with Cefazolin

While cefazolin is generally well-tolerated, it can cause various side effects ranging from mild to severe. Patients and healthcare providers should be aware of these potential adverse reactions.

Common Side Effects

• Gastrointestinal disturbances: nausea, vomiting, diarrhea
• Injection site reactions: pain, swelling, or redness
• Skin rashes or itching
• Elevated liver enzymes
• Candidiasis (yeast infection)

Serious Adverse Reactions

Although rare, some patients may experience more severe reactions to cefazolin:

• Anaphylaxis or severe allergic reactions
• Clostridium difficile-associated diarrhea
• Blood disorders: neutropenia, thrombocytopenia
• Seizures (particularly with high doses or in patients with renal impairment)
• Interstitial nephritis

How can the risk of side effects be minimized? To reduce the risk of adverse reactions, healthcare providers should carefully assess patient history, including allergies and previous reactions to antibiotics. Proper dosing, administration, and monitoring during treatment are essential for minimizing side effects and ensuring patient safety.

Drug Interactions and Precautions for Cefazolin Use

When prescribing cefazolin, it’s crucial to consider potential drug interactions and take necessary precautions to ensure safe and effective treatment.

Notable Drug Interactions

• Probenecid: May increase cefazolin levels in the blood
• Oral anticoagulants: Cefazolin may enhance the effects of these medications
• Aminoglycosides: Increased risk of nephrotoxicity when used concurrently
• Live bacterial vaccines: Cefazolin may reduce the effectiveness of these vaccines

Important Precautions

Healthcare providers should exercise caution when prescribing cefazolin in the following situations:

• Patients with a history of penicillin allergy
• Individuals with renal impairment (dose adjustment may be necessary)
• Patients with a history of gastrointestinal disease, particularly colitis
• Pregnant or breastfeeding women (cefazolin is generally considered safe, but risks and benefits should be weighed)

Can cefazolin be used safely in patients with penicillin allergy? While cross-reactivity between penicillins and cephalosporins like cefazolin is relatively low (around 5-10%), caution is still warranted. Patients with a history of severe immediate reactions to penicillins should be evaluated carefully before receiving cefazolin, and alternative antibiotics may be considered in some cases.

Dosage and Administration Guidelines for Cefazolin

Proper dosing and administration of cefazolin are crucial for achieving optimal therapeutic outcomes while minimizing the risk of adverse effects.

Adult Dosing

The typical adult dosage range for cefazolin varies depending on the type and severity of infection:

• Mild to moderate infections: 500 mg to 1 g every 6 to 8 hours
• Severe infections: 1 g to 1.5 g every 6 hours
• Surgical prophylaxis: 1 g to 2 g within 60 minutes before surgical incision

Pediatric Dosing

For children, dosing is typically based on body weight:

• 25 to 50 mg/kg/day divided into 3 or 4 equal doses
• For severe infections: up to 100 mg/kg/day may be used

Renal Dosing Adjustments

Patients with impaired kidney function may require dose adjustments to prevent drug accumulation:

• Creatinine clearance 35-54 mL/min: Full dose every 8 hours
• Creatinine clearance 11-34 mL/min: Full dose every 12 hours
• Creatinine clearance ≤10 mL/min: Half the usual dose every 18-24 hours

How long should cefazolin treatment typically last? The duration of cefazolin therapy depends on the type and severity of the infection being treated. For most infections, treatment typically lasts 7 to 14 days. However, some conditions may require longer courses of therapy. It’s essential to complete the full course of antibiotics as prescribed to prevent the development of antibiotic-resistant bacteria.

Cefazolin in Clinical Practice: Effectiveness and Considerations

Cefazolin has proven to be a valuable antibiotic in various clinical scenarios, demonstrating effectiveness in both treatment and prophylaxis of bacterial infections.

Surgical Prophylaxis

Cefazolin is widely used for surgical site infection prevention due to its:

• Broad spectrum of activity against common skin flora
• Favorable pharmacokinetics, achieving high tissue concentrations
• Relatively long half-life, allowing for single-dose administration in many procedures

Treatment of Infections

Cefazolin has shown efficacy in treating various bacterial infections, including:

• Skin and soft tissue infections caused by susceptible Staphylococcus and Streptococcus species
• Respiratory tract infections, particularly those caused by Streptococcus pneumoniae
• Urinary tract infections caused by susceptible gram-negative organisms
• Bone and joint infections, often used in combination with other antibiotics

Antimicrobial Stewardship Considerations

While cefazolin is an effective antibiotic, its use should be guided by antimicrobial stewardship principles to prevent the development of resistance:

• Reserve for confirmed or strongly suspected bacterial infections
• Use the narrowest spectrum antibiotic effective against the identified pathogen
• Avoid prolonged use when shorter courses are appropriate
• Consider local resistance patterns when selecting antibiotics

Is cefazolin always the best choice for treating bacterial infections? While cefazolin is an excellent option for many infections, it may not always be the optimal choice. The selection of antibiotics should be based on various factors, including the suspected pathogen, local resistance patterns, patient allergies, and site of infection. In some cases, other antibiotics may be more appropriate or effective.

Future Perspectives and Ongoing Research on Cefazolin

As antibiotic resistance continues to be a global concern, ongoing research and development efforts are focused on optimizing the use of existing antibiotics like cefazolin and exploring new applications.

Novel Formulations and Delivery Methods

Researchers are investigating new ways to enhance the effectiveness and reduce side effects of cefazolin:

• Extended-release formulations for prolonged drug activity
• Nanoparticle-based delivery systems for improved tissue penetration
• Combination therapies with other antibiotics or adjuvants to enhance efficacy

Expanding Indications

Studies are exploring the potential use of cefazolin in new clinical scenarios:

• Treatment of prosthetic joint infections
• Management of certain central nervous system infections
• Use in outpatient parenteral antimicrobial therapy (OPAT) programs

Resistance Monitoring and Mitigation

Ongoing surveillance and research efforts are aimed at:

• Tracking the development and spread of cefazolin-resistant bacterial strains
• Identifying mechanisms of resistance and potential ways to overcome them
• Developing rapid diagnostic tests to guide appropriate antibiotic selection

What role will cefazolin play in the future of antibiotic therapy? As antibiotic resistance continues to evolve, the role of cefazolin may change. While it remains an important antibiotic in current practice, its future use will likely be guided by ongoing research, resistance patterns, and the development of new antimicrobial agents. Continued research and judicious use of cefazolin will be crucial in preserving its effectiveness for future generations.

Cefazolin: Uses, Interactions, Mechanism of Action

Injection	Intramuscular	1 g/1
Injection	Intramuscular	10 g/1
Injection		1 G
Injection		250 MG
Injection		500 MG
Injection, powder, for solution	Intramuscular	250 MG
Injection, powder, for solution	Intramuscular	500 MG
Injection, powder, for solution	Intramuscular; Parenteral	1000 MG/4ML
Injection, powder, for solution	Intramuscular; Parenteral	250 MG/2ML
Injection, powder, for solution	Intramuscular; Parenteral	500 MG/2ML
Injection, powder, for solution	Intravenous; Parenteral	1000 MG/10ML
Injection, powder, for solution	Intramuscular
Injection	Intramuscular; Intravenous	1000 mg
Injection	Intramuscular; Intravenous	250 mg
Injection	Intramuscular; Intravenous	500 mg
Injection	Intramuscular	1 g/100mL
Injection	Intramuscular	500 mg/10mL
Injection	Intravenous	500 mg/50mL
Injection, powder, for solution	Intramuscular; Intravenous	1 g/1
Injection, powder, for solution	Intramuscular; Intravenous	1 g/3mL
Injection, powder, for solution	Intramuscular; Intravenous	2 g/1
Injection, powder, for solution	Intramuscular; Intravenous	225 mg/1mL
Injection, powder, for solution	Intramuscular; Intravenous	330 mg/1mL
Injection, powder, for solution	Intramuscular; Intravenous	500 mg/1
Injection, powder, for solution	Intramuscular; Intravenous	500 mg/2. 2mL
Injection, powder, for solution	Intramuscular; Intravenous	500 mg/10mL
Injection, powder, for solution	Intramuscular; Intravenous; Parenteral	1 g/1
Injection, powder, for solution	Intramuscular; Intravenous; Parenteral	500 mg/1
Injection, powder, for solution	Intravenous	1 g/1
Injection, powder, for solution	Intravenous	1 g/5mL
Injection, powder, for solution	Intravenous	10 g/1
Injection, powder, for solution	Intravenous	2 g/1
Injection, powder, for solution	Intravenous	20 g/100mL
Injection, powder, for solution	Intravenous	20 g/1
Injection, powder, for solution	Intravenous	3 g/1
Injection, powder, for solution	Intravenous	500 mg/1
Injection, powder, for solution	Intravenous; Parenteral	10 g/1
Injection, powder, lyophilized, for solution	Intramuscular	1 g/1
Injection, powder, lyophilized, for solution	Intravenous	100 g/1
Injection, powder, lyophilized, for solution	Intravenous	2 g/1
Injection, powder, lyophilized, for solution	Intravenous	300 g/1
Injection, solution	Intravenous	1 g/50mL
Powder, for solution	Intramuscular; Intravenous	1 g/3mL
Powder, for solution	Intramuscular; Intravenous	500 mg/2. 2mL
Powder, for solution	Intravenous	10 g/1
Powder, for solution	Intravenous	20 g/100mL
Powder, for solution	Intramuscular; Intravenous	1 g / vial
Powder, for solution	Intramuscular; Intravenous	500 mg / vial
Powder, for solution	Intravenous	10 g / vial
Powder, for solution	Intramuscular; Intravenous	20 g / vial
Injection, powder, for solution	Intramuscular; Intravenous	1 g
Powder, for solution	Intramuscular; Intravenous	1.0 g / vial
Powder, for solution	Intravenous	100 g / bag
Powder, for solution	Intravenous	20 g / vial
Solution	Intravenous	20 mg / mL
Injection, powder, for solution	Intramuscular; Intravenous	1 g/vial
Injection, powder, for solution	Intravenous
Injection, powder, for solution	Parenteral
Injection, solution	Intramuscular; Intravenous
Injection, powder, for solution
Injection, powder, for solution		1 g
Injection, solution	Intravenous	100 mg/1mL
Injection, solution	Intravenous	2 g/100mL
Injection, solution	Intravenous	30 mg/1mL
Solution	Intravenous	1 g/50mL
Solution	Intravenous	2 g/50mL
Powder, for solution	Intramuscular; Intravenous	2 g / vial
Injection, powder, lyophilized, for solution	Intramuscular; Intravenous	1 g
Injection, powder, for solution	Intramuscular; Intravenous
Injection, powder, lyophilized, for solution	Intramuscular; Intravenous	500 MG
Injection, powder, for solution	Intravenous
Powder	Intramuscular
Injection, powder, for solution	Intramuscular	1 g
Injection, powder, for solution	Intramuscular; Parenteral	1 G/4ML
Injection, powder, for solution	Intramuscular; Parenteral	500 MG/3ML
Injection, powder, for solution	Intravenous; Parenteral	1 G/10ML
Injection, powder, lyophilized, for solution	Parenteral	1 g
Injection, powder, for solution	Intravenous	250 MG
Injection, powder, for solution	Intravenous	500 MG
Injection, powder, for solution	Parenteral	1 G
Injection, powder, for solution	Parenteral	500 MG
Injection, solution	Intramuscular	1 g
Injection	Intramuscular	250 mg
Injection	Intramuscular	500 mg
Injection	Intramuscular; Intravenous	1 g
Injection	Intramuscular	1 g
Injection, powder, for solution	Intramuscular; Intravenous	1 gm
Injection, powder, for solution	Intramuscular; Intravenous	1 gr
Injection, powder, for solution	Intramuscular; Intravenous	250 mg
Injection, powder, for solution	Intramuscular; Intravenous	500 mg
Powder, for solution	Intravenous	1 g / vial
Powder, for solution	Intravenous	500 mg / vial
Injection, powder, for solution	Intramuscular	1000 mg
Injection	Intramuscular; Intravenous
Injection	Intramuscular	1000 mg
Powder, for solution	Intramuscular; Intravenous	10 g / vial
Injection
Injection, powder, for solution	Intramuscular
Powder, for solution
Injection, powder, for solution	Intramuscular; Intravenous	1000 mg
Powder	Intramuscular	250 mg/1vial
Powder	Intramuscular	500 mg/1vial

Cefazolin (Kefzol®, Ancef®) for dogs and Cats

PetPartners, Inc. is an indirect corporate affiliate of PetPlace.com. PetPlace may be compensated when you click on or make a purchase using the links in this article.

Overview of Cefazolin for dogs and Cats

This drug is not approved for use in animals by the Food and Drug Administration but it is prescribed legally by veterinarians as an extra-label drug.

Brand Names and Other Names of Cefazolin

Uses of Cefazolin for Dogs and Cats

Precautions and Side Effects

Cefazolin should not be used in animals with known hypersensitivity or allergy to the drug.

How Cefazolin Is Supplied

Dosing Information of Cefazolin for dogs and Cats

Medication should never be administered without first consulting your veterinarian.

<!–

Antibiotics & Antimicrobial Drugs

–>

<!–

Dentistry & Oral Cavity diseases
Dermatology & Integumentary diseases
Gastroenterology & Digestive diseases
Orthopedics & Musculo-Skeletal diseases
Respiratory & Thoracic diseases

–>

0 paws up

Share:

Dr. Dawn Ruben

July 17, 2015

Share:

Popular Posts

Pet Care

No More Compromises: The Roborock …

Diseases & Conditions of Dogs

Hip Dysplasia in Dogs …

Just For Fun

The Best Gifts for Dog Moms …

Previous / Next Article

Drug Library

Naproxen (Naprosyn®, Aleve®) for Dogs

Previous Article

Drug Library

Stanozolol (Winstrol®) for Dogs and Cats

Next Article

Drug Library

Naproxen (Naprosyn®, Aleve®) for Dogs

“NOBEL PHARMA”: our success is in our team!

Each country has its own local pharmaceutical manufacturing companies of different size and importance for the pharmaceutical market of their state. They can number from a few to hundreds. However, only a few of them become exactly the embodiment of the pharmacy of a particular power. Producers in a country like Turkey are no exception. Large modern pharmaceutical enterprises in this country have been developing and have been operating effectively for decades. During these decades, pharmaceutical enterprises have been constantly improving and modernizing; today they are equipped with Western European equipment, their production processes are certified and meet the requirements set by the global pharmaceutical community. However, for us, Ukrainians, the company “NOBEL PHARMA” has become the embodiment of Turkish pharmacy.

Founded in 1964, NOBEL PHARMA became part of Ulkar Holding in 1978, which is now a multinational pharmaceutical company headquartered in Istanbul, Turkey. Today, “NOBEL PHARMA” occupies a leading position in the Turkish pharmaceutical market due to the fact that it implements a successful marketing and sales strategy, which is supported by a vertical integration structure for the development and production of medicines. The products that this company represents are not just manufactured using the latest technologies in factories equipped with modern equipment – NOBEL PHARMA carries out a full cycle of drug development: from an idea to a finished product. The development of ideas takes place in the laboratories of the Fargem company, which is the R&D division of Ulkar Holding, the production of substances – at the Ulkar Kimiya enterprise located in Turkey, and the production of finished dosage forms – at the enterprises of Nobel Farma (Turkey), ” Nobel AFF” (Uzbekistan) and “Nobel Pharmsanoat” (Kazakhstan). It would not be superfluous, perhaps, to note that the company’s production facilities meet GMP requirements, which is provided for in Turkey at the legislative level.

Over time, NOBEL PHARMA products gradually conquered the pharmaceutical markets of Eastern Europe (Bulgaria, Romania, Serbia, Bosnia and Herzegovina), the CIS (Russia, Belarus, Moldova, Georgia, Azerbaijan), Central Asia (Uzbekistan, Kazakhstan, Kyrgyzstan). And in 2006, NOBEL PHARMA also came to Ukraine, where, thanks to its vast experience in entering local markets, it successfully implements its development strategy, adapted to national characteristics and needs.

And although NOBEL PHARMA and its products have been on the Ukrainian pharmaceutical market for only 5 years, many of us associate the Turkish drug manufacturer with this company, which, you see, cannot be an accident. At the same time, there is no need to conduct an in-depth analysis of the reasons in order to understand why it happened this way, because the answer lies on the surface. This, of course, is a significant intellectual and human potential of the manufacturing company, as well as its modern and powerful production base, high quality products, a well-thought-out management model that allows you to make the necessary decisions in the shortest possible time, as well as a well-organized and trained external service of the company, allowing to implement the main tasks of promoting the product portfolio as efficiently as possible.

How great is the role of personnel and the importance of training regional and medical representatives of any pharmaceutical company, we were able to see by recently visiting one of the picturesque country hotel complexes, where an internal training was held, which brought together the vast majority of employees of the Ukrainian representative office of NOBEL PHARMA. We talked about the company, its place in the Ukrainian pharmaceutical market and the importance of training pharmaceutical staff in between sessions with the CEO of NOBEL PHARMA in Ukraine, Jem Demirdzhi:

— Recently, we have been hearing more and more often that emerging markets are the most promising and that the largest pharmaceutical players have been refocusing on them in recent years. The Ukrainian market is no exception, and when planning its expansion to the CIS pharmaceutical markets, NOBEL PHARMA could not but take into account its dynamic development. This was the reason why, already in May 2005, the Ukrainian representative office of our company was opened. Having started with the launch of 4 products, already today NOBEL PHARMA markets more than 15 products on the Ukrainian market and has branches in most of the largest cities in the country, having gathered an experienced team of 80 regional and medical representatives on its staff.

All our employees are, of course, employees with many responsibilities, each of which, without exaggeration, is responsible for the successful work of the entire team. Some of them have to regulate the work of medical representatives, as well as directly implement the company’s product and personnel policy, often act as a business coach, lecturer or consultant for their direct subordinates, others have to establish cooperation with doctors, pharmacists of the first table, and pharmacy managers and clinics, select opinion leaders. Such a multifaceted and wide list of tasks facing our employees, of course, makes us pay quite a lot of attention to staff training. This is also important because every year both the company’s product portfolio, represented on the Ukrainian pharmaceutical market, and the staff of the representative office are increasing.

Today, the NOBEL PHARMA company offers the Ukrainian consumer high-quality medicines that are used for a wide range of indications, for example, in the treatment of respiratory diseases and diseases of the cardiovascular system, including flu and cold complications, inflammatory processes, fungal infections, etc. For example, complex preparations TYLOL HOT Fen and ANZIBEL are very relevant for this period, when the incidence of colds and flu is increased.

Due to the complex composition of the preparation TYLOL HOT Fen in the form of powder for preparing a hot drink, we can effectively influence the main mechanisms of the development of cold symptoms. So, paracetamol has an antipyretic, anti-inflammatory and analgesic effect, and chlorpheniramine maleate eliminates swelling and inflammation of the mucous membranes of the upper respiratory tract.

ANZIBEL in its composition is an original drug that has no analogues on the Ukrainian market. The drug is indicated for acute pharyngitis (sore throat) and effectively eliminates even severe pain. ANZIBEL has a wide spectrum of antiseptic action, actively fighting the pathological microflora located on the mucous membrane of the oropharynx. A distinctive feature of the drug is that, in addition to all the above properties, due to the enoxolone included in its composition, ANZIBEL has anti-inflammatory properties, which also helps to alleviate the patient’s condition with acute pharyngitis, reduce swelling of the oropharyngeal mucosa, improve tissue regeneration and, most importantly, – ANZIBEL has a pronounced antiviral effect, which makes it a particularly valuable drug in the treatment of patients with sore throat of viral etiology.

Of course, it is impossible not to mention such a popular over-the-counter drug among Ukrainian consumers as ALORA, which is based on passionflower extract. This is a monocomponent sedative herbal preparation, presented in the form of syrup and tablets, which has a calming and mild hypnotic effect. Since entering the Ukrainian pharmaceutical market, it has been in regular and growing demand among stressed patients who are worried about insomnia, increased irritability and anxiety.

However, in addition to OTC drugs, the assortment of NOBEL PHARMA has a very wide range of prescription group. Among them are such trademarks well-known to the Ukrainian doctor and the pervostolnik as LANSOPROL (lansoprozol), PULCET (pantoprazole), LIPOFEN SR (fenofibrate), MELBEK (meloxicam), FLUNOL (fluconazole), ETOL FORT (etodolac), as well as oral antibiotics. use and parenteral administration – AZAX (azithromycin), AKSEF (cefuroxime), etc.

Of course, not only the constant expansion of the range of products, but also the increasing size of the team, which is replenished every time with more and more new specialists, force us to conduct trainings like the one whose guests were the correspondent of APTEKA Weekly. After all, the work of each employee of the external service, as well as the company as a whole, must be carried out in accordance with the market concepts of the 21st century, including ethical standards for the promotion of medicines. Today, we could observe, for example, how much importance in the training program was given to preparing foreign service employees for a visit to a pharmacy and the technique of the visit itself, as well as training in the art of working in the trading floor of a pharmacy, the principles of establishing cooperation with doctors and first capitalists, as well as heads of pharmacies . Moreover, such knowledge is very often important not only for medical representatives, but also for regional leaders. All these skills, of course, combine rigorous science with the virtuosic art of effective work in the market.

However, the regular conduct of such internal trainings allows not only to conduct and control the quality of training, to acquaint our employees with internal work standards, to remind or tell something new about products – they also allow them to get to know each other, establish informal relationships, which is of no small importance important for the future performance of the entire company. After all, it is this approach, according to NOBEL PHARMA, that contributes to the creation of a cohesive team.

Perhaps that is why the team called “NOBEL PHARMA” employs initiative people who sincerely love their work and believe in success!

Ilan Bril,
photo by Sergey Bek

The first independent review site of Ukraine

Select the section you are interested in from the list of ratings. All ratings are based on user reviews. Your opinion and feedback can be very important for hundreds of thousands of users who visit our site every day.

Mist Express is a delivery service that is part of the postal and logistics group founded in 1992 by the international corporation Meest Corp. Inc. (Toronto,…

Nova Poshta Group offers its clients, both business and private persons, a wide range of logistical and related services…

Euromaidan in Kiev started on November 21, 2013, in the form of a rally protest against the suspension of the process of preparing the signing of the Agreement by the Cabinet of Ministers of Ukraine. ..

The Ukrainian state undertaking of the postal communication service “Ukrposhta” (UDPPZ “Ukrposhta”) is included in the sphere of administration of the Ministry of Transport and Communications of Ukraine, and the national operator…

OLX is the largest online platform in Ukraine ads, where ordinary Ukrainians, private users, can sell any product, provide any service….

Kyivstar is a national mobile operator. Our mission is to provide quality, reliable and affordable mobile communications as possible…

Vodafone Group is a British company, one of the world’s largest mobile operators. The headquarters is in Newbury, county…

“1+1” is a nationwide Ukrainian-language TV channel, one of the leaders in domestic TV production and the most favorite TV channels of Ukrainian viewers.
Channel “1+1” was released in…

World brands with home delivery
Ukraine’s fashion hypermarkets have a serious competitor. Lamoda.ua, an online store of clothes, shoes and accessories of the European level,. ..

Online store Rozetka.ua is by far the most popular electronics and home appliances store in Ukraine. And there are representative offices of our company…

Comfy – supermarkets and an online store of home appliances and electronics. A network of household appliances and electronics stores in Kiev and Ukraine

Leading “Inspector” Olga Freimut (the face of Euro 2012 in Ukraine and an official friend of Euro 2012) checks everything with unique and touching curiosity…

RETAIL NETWORK “ALLO-telecom”
Founded in 1998.
The goal of “ALLO-telecom” is to be the No. 1 retail solution in Ukraine for both mobile and…

MTS Company is a pioneer of mobile communication in Ukraine. Every second Ukrainian uses MTS communications. Since 2003, the company has been a member of the…

Shvidko groshi is a rapidly growing company that offers loans without collateral. The company’s specialists promise all customers high-quality express service.
Take…

Busfor.ua is a modern online service for the sale of bus tickets for trips around Ukraine and Europe. The Busfor.ua team takes into account…

Eldorado.ua is the leading chain of home appliances and electronics in Ukraine.
At the beginning of 2023, there are 94 stores, an online store and a mobile application…

Shafa (shafa.ua). A woman must be beautiful and attractive. The choice of clothing is one of the main criteria in this matter. Looking at…

Merezha AZK OKKO (“Galnaftogaz Concern”) enters the warehouse of OKKO Group and is one of the largest gas stations in Ukraine, w…

Ying-Time is a national delivery service that provides a full range of services for express delivery of goods in Ukraine. We deliver goods from…

Citrus Company is the first Ukrainian specialized network of gadgets and accessories stores.
The company was founded in 2000. Today, “Citrus” is represented by more than…

Kabanchik.